Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell? It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

A team at Memorial Sloan Kettering has been working to improve those outcomes by developing a new mRNA vaccine for pancreatic cancer. A few years ago, the team embarked on a small trial to test the ...

Together, we intend to accelerate the field of next-generation medicines in mRNA and CRISPR, using best-in-class chemistries, processes, and proprietary technologies like CleanCap ® analogs ...

Shares of the bank stocks JPMorgan Chase (NYSE: JPM) and Wells Fargo (NYSE: WFC) fell 1.7% and 2.2%, respectively, for no obvious reason but likely due to new economic data and ongoing tariff news ...

Forbes contributors publish independent expert analyses and insights.

Pancreatic cancer is one of the deadliest cancers. But those battling the disease saw promising results in the small clinical trial of an mRNA vaccine.